Bracco Diagnostics Unveils Contrast Media and Device Offerings at RSNA 2019

Bracco Imaging develops, manufactures, and markets diagnostic imaging agents and solutions that meet medical needs. Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities, including X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers. The diagnostic imaging portfolio is completed by a range of medical devices and advanced administration systems for contrast imaging products.

At RSNA 2019, Bracco Diagnostics highlighted its focus on patient care and the power of choice, giving customers the ability to assess each patient's personal needs and decide upon the best contrast media option for their patients, whether the contrast is for an MRI, X-ray/CT, Ultrasound, or Nuclear Medicine examination. The company also stated its commitment towards smart solutions and innovative technologies to improve workflow, optimize image quality, and maximize efficiency. Bracco Diagnostics expressed its dedication and passion for funding education for the medical community with comprehensive, convenient programs tailored to address today's health care challenges. It offered interactive carousels for RSNA attendees to explore the company’s offerings and clinical breakthroughs to improve outcomes.

"We come to this year's RSNA eager to discuss the science of imaging with our customers and our industry partners," said Cosimo De Pinto, Vice President of Marketing at Bracco. "To say the next few years are going to be transformational would be an understatement. The balance of providing value-based care while riding the wave of technology and innovation can be daunting for our customers, but we believe we are in a unique position at Bracco to support both endeavors. It's an exciting time to be in the field of diagnostic imaging."

Related Links:
Bracco Diagnostics Inc.